SLIT™ Amikacin
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Insmed Incorporated
Overview
SLIT™ Amikacin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
SLIT™ Amikacin clinical trials
Explore related
Medical disclaimer. This page summarizes research about SLIT™ Amikacin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.